跳至主要内容
临床试验/NCT05913960
NCT05913960招募中不适用

the Mechanism of Accelerated Intermittent Theta Burst Stimulation for Rapid Treatment of Major Depressive Disorder Based on the Prefrontal Excitation-inhibition Balance Regulated by CAMKII Pathway

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年2月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
90
试验地点
1
主要终点
Hamilton depression scale-24

研究概览

简要总结

Major depressive disorder(MDD) is a complex and heterogeneous mental disorder. Repeated transcranial magnetic stimulation (rTMS), as a non-invasive neuroregulatory technique, has shown a promising function in the treatment of depression. Theta-burst transcranial magnetic stimulation (TBS) model significantly shortened the duration of physical therapy treatment, and iTBS under the accelerated model (The latter is referred to as aiTBS)showed promising therapeutic effect. However, whether aiTBS has a better and faster curative effect in the first untreated or recurrent unmedicated MDD patients and the mechanism of its alleviation of depressive symptoms remains unclarified. This project intends to verify changes in CAMKII levels, CAMKII molecules and GABA receptors in brain-derived exosomes in normal controls and patients who received sham, aiTBS and high-frequency (10Hz) stimulation respectively. Neuroimaging and TMS-EEG were used to pinpoint the target of stimulation and to record the changes of brain waves before and after treatment in real time. To clarify the neurobiological mechanism of aiTBS rapidly improving depression, and to provide a new strong evidence for clinical transcranial magnetic stimulation for accurate treatment of MDD patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Sign a written informed consent to participate in the trial and receive treatment;
  • Major depressive disorder diagnosis;
  • Hamilton depression scale (HAMD - 24) 24 total score 20 points or more;
  • First episode or recurrence of depression patients, not taking psychiatric drugs;
  • The han nationality, right-handed;
  • Junior high school or above;

排除标准

  • Other organic mental disorders and mental retardation and other severe mental disorders;
  • Infection, trauma, and autoimmune diseases or other possible interference test evaluation of disease;
  • Alcohol and drug dependence or is being treated for a hormone drugs patients;
  • Craniocerebral injury;
  • Seizure or a family history of epilepsy;
  • Pregnancy and lactation women;
  • All landowners had a metal and MRI contraindications or MRI examination revealed abnormal brain structure.

结局指标

主要结局

Hamilton depression scale-24

时间窗: 4 weeks

Assessement of depressive status,a score of more than 35 May indicate severe depression; More than 20 points, may be mild or moderate depression; A score of less than 8 indicates no symptoms of depression

次要结局

  • Change in the score of THINC-it.(4 weeks)
  • Change in neuroimaging using functional magnetic resonance(5 days)
  • Change of blood factor levels(4 weeks)
  • Change in electroencephalogram(5 days)
  • Hamilton anxiety scale(4 weeks)

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验